Evidence map›Paper›PMID 20151474›Full record

ReviewDevelopmental dynamics : an official publication of the American Association of Anatomists2010

Developmental biomarkers of aging in Caenorhabditis elegans.

Zachary Pincus, Frank J Slack

Open access · bronzeAbstract readReview
In one paragraph

Review in Developmental dynamics : an official publication of the American Association of Anatomists, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Caenorhabditis elegans as a Screening Platform for Anti-aging Compounds.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Journal of clinical biochemistry and nutrition · 2022
    Article
  12. Article
  13. Extracts of the Tiger Milk Mushroom (Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  14. Enhanced Healthspan inFrontiers in pharmacology · 2021
    Article
  15. Article
  16. Article
  17. Healthspan Enhancement by Olive Polyphenols inInternational journal of molecular sciences · 2020
    Article
  18. Article
  19. Review
  20. Antiaging, Stress Resistance, and Neuroprotective Efficacies ofOxidative medicine and cellular longevity · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zachary PincusDepartment of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.
Frank J Slack
Yale University · US

Funding

MicroRNAs in agingR01AG033921 · NIA · YALE UNIVERSITY · PI SLACK, FRANK J. · 2009 to 2018
$3.3M
NIA NIH HHS AG033921NIA NIH HHS R01 AG033921
6 · The paper itself

Abstract

The developmental process of the nematode Caenorhabditis elegans is famously invariant; however, these animals have surprisingly variable lifespans, even in extremely homogenous environments. Inter-individual differences in muscle-function decline, accumulation of lipofuscin in the gut, internal growth of food bacteria, and ability to mobilize heat-shock responses all appear to be predictive of a nematode's remaining lifespan; whether these are causal, or mere correlates of individual decline and death, has yet to be determined. Moreover, few "upstream" causes of inter-individual variability have been identified. It may be the case that variability in lifespan is entirely due to stochastic damage accumulation; alternately, perhaps such variability has a developmental origin and/or genes involved in developmental canalization also act to buffer phenotypic heterogeneity later in life. We review these two hypotheses with an eye toward whether they can be experimentally differentiated.

Indexed as

AgingAnimalsBiomarkersCaenorhabditis elegansGrowth and DevelopmentLongevityBiomarkers

Identifiers

PMID20151474
PMCPMC3073312
OpenAlexW2084621966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.